ArticleObesity surgery2025
Short-Term Outcomes of 400-cm Common Limb SADI-S in Chinese Patients with Obesity of BMI < 35 kg/m
Article in Obesity surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
The aim of this study was to evaluate the short-term efficacy of single-anastomosis duodeno-ileostomy with sleeve gastrectomy (SADI-S) using a 400-cm common limb in Chinese patients with obesity of low BMI (<35 kg/m²) and type 2 diabetes (T2D). Sixteen patients who underwent SADI-S between June 2022 and November 2023 were retrospectively analyzed and evaluated at 6 and 12 months postoperatively. The primary outcome was the rate of diabetes remission (HbA1c < 6.5% without antidiabetic medications for ≥ 3 months). Secondary outcomes included excess and total weight loss (EWL and TWL) and nutritional deficiencies. At 12 months postoperatively, 80% of patients achieved diabetic remission, with mean HbA1c decreasing from 8.84 ± 1.55 to 5.93 ± 0.74%. Mean BMI decreased from 30.64 ± 2.29 to 22.91 ± 2.33 kg/m², and EWL and TWL reached 122.12% ± 44.43% and 25.01% ± 8.02%, respectively. Nutritional status remained stable with no cases of hypoalbuminemia and fewer iron and vitamin deficiencies. SADI-S with a 400-cm common limb was effective in achieving glycemic control and weight loss while reducing the risk of nutritional deficiencies in Chinese patients with obesity of low BMI and T2D.
Indexed as
Identifiers
40029462What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.